Form 4 for PGEN PRECIGEN, INC.
Accepted 2026-07-01 18:19:25 ET · period of report 2026-06-29 · accession 0000950103-26-009978 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-07-01 18:19 | 2026-06-29 | PGEN | Sabzevari Helen | Pres, CEO | M - OptEx | $2.33 | +346.8K | 4.12M | +9% | +$808.1K |
| DT | 2026-07-01 18:19 | 2026-06-29 | PGEN | Sabzevari Helen | Pres, CEO | S - Sale+OE | $5.89 | -346.8K | 3.77M | -8% | -$2.04M |
| DT | 2026-07-01 18:19 | 2026-06-29 | PGEN | Sabzevari Helen | Pres, CEO | M - OptEx | $0.00 | -346.8K | 500.2K | -41% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-29 | M | A | 346,836 | $2.33 | 4,115,708 | D | — | — | |
| 2 | Common | Common Stock | 2026-06-29 | S | D | 346,836 | $5.89 | 3,768,872 | D | — | — | (F1) Represents shares sold pursuant to the terms of a 10b5-1 plan adopted by the reporting person. (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.75 to $6.04, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. |
| 3 | Derivative | Option to Purchase Common Stock (Right to Buy) | 2026-06-29 | M | D | 346,836 | $0.00 | 500,164 | D | $2.33 · — to 2032-02-02 | 346,836 Common Stock | (F3) The stock options are fully vested. |